GLP-3R 30MG is a synthetic peptide that activates the GLP-1, GIP, and glucagon receptors, making it a valuable tool for metabolic research. Researchers study this compound for its effects on metabolic signaling pathways, weight regulation, glycemic control, and overall metabolic health.

Its triple-receptor activity enables broader pathway engagement compared to single-agonist compounds, supporting investigation into synergistic mechanisms relevant to obesity and diabetes models.

This compound is intended exclusively for laboratory research and is not approved for human use.